Abstract
Clinical-laboratory analysis of the effectiveness of VIFERON® (suppositories rectal) in children from 1 month up to 7 years with acute respiratory viral infections (ARVI), accompanied by acute stenosing laryngotracheitis (ASLT), hospitalized in Children's City Clinical Hospital №5 named after N.F. Filatov. We have found that the drug VIFERON® helps statistically significant reduction in the duration of all major clinical manifestations of the disease as a whole, and also reduces the severity and duration of clinical symptoms ASLT, and significantly contributes to the faster elimination of viral antigens.
Highlights
Острые стенозирующие ларинготрахеиты (ОСЛТ) являются одними из самых опасных для жизни осложнений острых респираторных вирусных инфекций (ОРВИ) у детей [1]
We have found that the drug VIFERON® helps statistically significant reduction in the duration of all major clinical manifestations of the disease as a whole, and reduces the severity and duration of clinical symptoms acute stenosing laryngotracheitis (ASLT), and significantly contributes to the faster elimination of viral antigens
Conflict of interest: The authors confirmed the absence conflict of interest, which should be reported
Summary
Clinical-laboratory analysis of the effectiveness of VIFERON® (suppositories rectal) in children from 1 month up to 7 years with acute respiratory viral infections (ARVI), accompanied by acute stenosing laryngotracheitis (ASLT), hospitalized in Children's City Clinical Hospital No5 named after N.F. Filatov. Этиотропная терапия острых респираторных вирусных инфекций со стенозирующими ларинготрахеитами. For citation: V.N. Timchenko, V.F. Sukhovetskaya, T.A. Kaplina, L.M. Pochiniaeva, S.L. Bannova, M.D. Subbotina, O.V. Bulina, J.K. Khakizimana. Острые стенозирующие ларинготрахеиты (ОСЛТ) являются одними из самых опасных для жизни осложнений острых респираторных вирусных инфекций (ОРВИ) у детей [1]. Этиотропная терапия острых респираторных вирусных инфекций со стенозирующими ларинготрахеитами антиоксидантами — ВИФЕРОН® (суппозитории ректальные) [8, 9]. Цель исследования — изучить эффективность применения препарата ВИФЕРОН® (суппозитории ректальные) у детей при ОРВИ, сопровождающихся синдромом ОСЛТ
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
